Yellow |
Metabolic pathways |
242 |
2.03 × 10−11
|
Pathways of neurodegeneration—multiple diseases |
78 |
1.14 × 10−4
|
Alzheimer disease |
72 |
2.45 × 10−6
|
Amyotrophic lateral sclerosis |
66 |
2.18 × 10−5
|
Cell cycle |
59 |
9.41 × 10−19
|
White |
Pathways in cancer |
65 |
0.039962252 |
Huntington disease |
41 |
0.038434334 |
Endocytosis |
39 |
0.003801247 |
Hepatocellular carcinoma |
32 |
3.90 × 10−4
|
Tight junction |
32 |
3.90 × 10−4
|
Purple |
Metabolic pathways |
188 |
1.91 × 10−5
|
Herpes simplex virus 1 infection |
84 |
2.43 × 10−7
|
Chemical carcinogenesis—reactive oxygen species |
31 |
0.0235166 |
Biosynthesis of cofactors |
29 |
2.67 × 10−4
|
Peroxisome |
25 |
2.02 × 10−7
|
Turquoise |
Pathways in cancer |
85 |
2.89 × 10−6
|
PI3K-Akt signaling pathway |
63 |
4.31 × 10−6
|
MAPK signaling pathway |
52 |
3.76 × 10−5
|
Rap1 signaling pathway |
45 |
6.60 × 10−7
|
Regulation of actin cytoskeleton |
44 |
1.50 × 10−5
|
Royal Blue |
Endocytosis |
33 |
0.047955 |
Cytoskeleton in muscle cells |
31 |
0.044336 |
Hepatocellular carcinoma |
24 |
0.04709 |
mTOR signaling pathway |
23 |
0.03917 |
Nucleocytoplasmic transport |
22 |
1.84 × 10−5
|
Red |
Metabolic pathways |
202 |
2.29 × 10−6
|
Pathways of neurodegeneration—multiple diseases |
62 |
0.015828 |
Cell cycle |
58 |
6.81 × 10−20
|
Alzheimer disease |
54 |
0.006263 |
Amyotrophic lateral sclerosis |
51 |
0.008789 |
Cyan |
Metabolic pathways |
240 |
4.52 × 10−9
|
Pathways of neurodegeneration—multiple diseases |
84 |
1.69 × 10−5
|
Alzheimer disease |
77 |
3.46 × 10−7
|
Amyotrophic lateral sclerosis |
70 |
6.20 × 10−6
|
Cell cycle |
65 |
2.89 × 10−22
|
Dark Turquoise |
Pathways in cancer |
80 |
3.49 × 10−4
|
MAPK signaling pathway |
47 |
0.003029 |
Shigellosis |
40 |
0.004202 |
Focal adhesion |
39 |
1.49 × 10−4
|
Cytoskeleton in muscle cells |
39 |
0.002129 |